Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience

Background: Results of second-line chemotherapy in patients with extragonadal non-seminomatous germ cell tumor (NSGCT) appear inferior to results in testicular NSGCT. Patients with retroperitoneal NSGCT achieve a comparable long-term survival rate of 30%, but the salvage rates of patients with media...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2005-01, Vol.16 (1), p.146-151
Hauptverfasser:	De Giorgi, U., Demirer, T., Wandt, H., Taverna, C., Siegert, W., Bornhauser, M., Kozak, T., Papiani, G., Ballardini, M., Rosti, G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Cisplatin - administration & dosage Databases, Factual Disease-Free Survival EBMT extragonadal Female high-dose chemotherapy Humans Male Mediastinal Neoplasms - drug therapy Mediastinal Neoplasms - pathology Medical sciences Middle Aged Neoplasms, Germ Cell and Embryonal - drug therapy Neoplasms, Germ Cell and Embryonal - pathology non-seminomatous germ cell tumor Pharmacology. Drug treatments Prognosis Retroperitoneal Neoplasms - drug therapy Retroperitoneal Neoplasms - pathology Retrospective Studies Salvage Therapy second-line chemotherapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!